eMedicine Specialties > Thoracic Surgery > Tumors

Thymic Tumors: Follow-up

Author: Dale K Mueller, MD, Associate Professor of Surgery, Section Chief, Department of Surgery, University of Illinois at Peoria; Co-Medical Director, Thoracic Center of Excellence, Vice-Chair, Department of Cardiovascular Medicine and Surgery, OSF St Francis Medical Center; Cardiovascular and Thoracic Surgeon, HeartCare Midwest, SC
Contributor Information and Disclosures

Updated: Sep 3, 2008

Outcome and Prognosis

Prognosis after resection of a mediastinal tumor varies widely depending on the type of lesion resected. After resection of mediastinal cysts and benign tumors, prognosis is generally excellent. Thymic neoplasms included in this group are thymolipomas. Prognosis after treatment of malignant mediastinal tumors depends on the type of lesion, its biological behavior, and the extent of the disease present.

Thymoma

Thymomas are not considered benign neoplasms. Survival rates associated with tumors that are encapsulated or stage I is 95-97% at 5 years and 80-95% at 10 years.

Invasive or stage II tumors are associated with a reduced 5-year survival rate of 60-70% and a 10-year survival rate of 40-50%.

Survival rates for stage III tumors are reported to be less than 60% at 5 years and 14% at 10 years.

Survival rates for stage IVA tumors have been reported at 40% for 5 years and 0% at 10 years.

Other thymic malignancies

Squamous cell carcinoma of the thymus is quite rare, with fewer than 200 cases reported in the literature. Prognosis is considered excellent in cases of well-differentiated squamous cell tumors found and resected early. Poorly differentiated tumors have a uniformly poor prognosis.

The overall cure rate for neuroendocrine tumors of the thymus is low. One series reports a 13% 5-year survival rate.

The survival rate for patients with thymic epithelial neoplasms is 77% at 5 years. Risk factors with prognostic significance included staging and histologic type.

Future and Controversies

A number of exciting advances have been made in areas of diagnostic imaging, biologic analysis, and therapy.

Emerging diagnostic modalities such as PET scanning and other radionuclide studies may assist in the diagnosis of specific neoplasms and in posttherapy surveillance for recurrent disease. PET scanning has preliminarily demonstrated the ability to differentiate benign thymomas and malignant thymomas.

Numerous biological markers have been identified for many tumors and will play a vital role in better identifying individual neoplasms so that treatment can be optimized.

Use of VATS and robotic technology has entered the armamentarium of the thoracic surgeon with respect to the treatment of a number of mediastinal diseases. This modality is already commonly used for biopsy of masses and lymph nodes. It has also been described for resection of various mediastinal cysts, mediastinal parathyroid adenomas, and localized benign tumors of the posterior mediastinum, such as ganglioneuromas. The success of these modalities will be determined by data obtained in the long-term follow-up of cases. Because these neoplasms grow slowly, these data are not yet available.

 
Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Jane M Eggerstedt, MD to the development and writing of this article.



More on Thymic Tumors

Overview: Thymic Tumors
Workup: Thymic Tumors
Treatment: Thymic Tumors
Follow-up: Thymic Tumors
Multimedia: Thymic Tumors
References

References

  1. Kubota K, Yamada S, Kondo T, et al. PET imaging of primary mediastinal tumours. Br J Cancer. Apr 1996;73(7):882-6. [Medline].

  2. Liu RS, Yeh SH, Huang MH, et al. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Eur J Nucl Med. Dec 1995;22(12):1402-7. [Medline].

  3. Greif J, Staroselsky AN, Gernjac M, et al. Percutaneous core needle biopsy in the diagnosis of mediastinal tumors. Lung Cancer. Sep 1999;25(3):169-73. [Medline].

  4. Protopapas Z, Westcott JL. Transthoracic hilar and mediastinal biopsy. J Thorac Imaging. Oct 1997;12(4):250-8. [Medline].

  5. Rieger R, Schrenk P, Woisetschlager R, Wayand W. Videothoracoscopy for the management of mediastinal mass lesions. Surg Endosc. Jul 1996;10(7):715-7. [Medline].

  6. Demmy TL, Krasna MJ, Detterbeck FC, et al. Multicenter VATS experience with mediastinal tumors. Ann Thorac Surg. Jul 1998;66(1):187-92. [Medline].

  7. Rea F, Bortolotti L, Girardi R, Sartori F. Thoracoscopic thymectomy with the 'da Vinci' surgical system in patient with myasthenia gravis. Interact Cardiovasc Thorac Surg. Mar 2003;2(1):70-2. [Medline].

  8. Bacha EA, Chapelier AR, Macchiarini P, et al. Surgery for invasive primary mediastinal tumors. Ann Thorac Surg. Jul 1998;66(1):234-9. [Medline].

  9. Geibel A, Kasper W, Keck A, et al. Diagnosis, localization and evaluation of malignancy of heart and mediastinal tumors by conventional and transesophageal echocardiography. Acta Cardiol. 1996;51(5):395-408. [Medline].

  10. Giron J, Fajadet P, Sans N, et al. Diagnostic approach to mediastinal masses. Eur J Radiol. Mar 1998;27(1):21-42. [Medline].

  11. Kaga K, Nishiumi N, Iwasaki M, Inoue H. Thoracoscopic diagnosis and treatment of mediastinal masses. Usefulness of the Two Windows Method. J Cardiovasc Surg (Torino). Feb 1999;40(1):157-60. [Medline].

  12. Kaiser LR. Thoracoscopic resection of mediastinal tumors and the thymus. Chest Surg Clin N Am. Feb 1996;6(1):41-52. [Medline].

  13. Klemm KM, Moran CA. Primary neuroendocrine carcinomas of the thymus. Semin Diagn Pathol. Feb 1999;16(1):32-41. [Medline].

  14. Laurent F, Latrabe V, Lecesne R, et al. Mediastinal masses: diagnostic approach. Eur Radiol. 1998;8(7):1148-59. [Medline].

  15. Luketich JD, Ginsberg RJ. The current management of patients with mediastinal tumors. Adv Surg. 1996;30:311-32. [Medline].

  16. Meade RH. Surgery of the Mediastinum. In: A History of Thoracic Surgery. Springfield, Ill: Charles C. Thomas; 1961:. 257-71.

  17. Pai KR, Thonse VR, Azadeh B, Page RD. Ectopic thymoma of the chest wall. Interactive CardioVascular Thoracic Surgery. 2005;4:9-11.

  18. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg. Aug 1996;112(2):376-84.

  19. Ritter JH, Wick MR. Primary carcinomas of the thymus gland. Semin Diagn Pathol. Feb 1999;16(1):18-31. [Medline].

  20. Ríos A, Torres J, Galindo PJ, et al. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg. Feb 2002;21(2):307-13. [Medline].

  21. Sasaki M, Kuwabara Y, Ichiya Y, et al. Differential diagnosis of thymic tumors using a combination of 11C-methionine PET and FDG PET. J Nucl Med. Oct 1999;40(10):1595-601. [Medline].

  22. Serna DL, Aryan HE, Chang KJ, et al. An early comparison between endoscopic ultrasound-guided fine-needle aspiration and mediastinoscopy for diagnosis of mediastinal malignancy. Am Surg. Oct 1998;64(10):1014-8. [Medline].

  23. Shields TW. Overview of primary mediastinal tumors and cysts. In: Shields TW, LoCicero J III, Ponn RB, eds. General Thoracic Surgery. Vol 2. 5th ed. Philadelphia, Pa: Williams and Wilkins; 2000:2105-9.

  24. Shields TW. Thymic tumors. In: Shields TW, LoCicero J III, Ponn RB, eds. General Thoracic Surgery. Vol 2. 5th ed. Philadelphia, Pa: Williams and Wilkins; 2000:2181-205.

  25. Shin HJ, Katz RL. Thymic neoplasia as represented by fine needle aspiration biopsy of anterior mediastinal masses. A practical approach to the differential diagnosis. Acta Cytol. Jul-Aug 1998;42(4):855-64. [Medline].

  26. Strollo DC, Rosado de Christenson ML, Jett JR. Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest. Aug 1997;112(2):511-22. [Medline].

  27. Virgo KS, Johnson FE, Naunheim KS. Follow-up of patients with thoracic malignancies. Surg Oncol Clin N Am. Apr 1999;8(2):355-69. [Medline].

  28. Whooley BP, Urschel JD, Antkowiak JG, Takita H. Primary tumors of the mediastinum. J Surg Oncol. Feb 1999;70(2):95-9. [Medline].

Further Reading

Keywords

thymoma, thymic tumor, benign tumor, tumor, thymic cyst, carcinoma of the thymus, carcinoid tumor of the thymus, thymolipomas, mediastinal surgery, mediastinal tumor, cystic tumor, mediastinum surgery, dermoid cyst, teratoma, mediastinal mass, mediastinal tumor, thymic carcinomas, thymic neuroendocrine tumors, thymic hyperplasia, thymic carcinoids, myasthenia gravis, thymic rebound, thymus neoplasm, thymus gland

Contributor Information and Disclosures

Author

Dale K Mueller, MD, Associate Professor of Surgery, Section Chief, Department of Surgery, University of Illinois at Peoria; Co-Medical Director, Thoracic Center of Excellence, Vice-Chair, Department of Cardiovascular Medicine and Surgery, OSF St Francis Medical Center; Cardiovascular and Thoracic Surgeon, HeartCare Midwest, SC
Dale K Mueller, MD is a member of the following medical societies: American College of Chest Physicians, American College of Surgeons, American College of Surgeons, American Medical Association, American Medical Writers Association, Chicago Medical Society, Illinois State Medical Society, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

Medical Editor

Richard Thurer, MD, B and Donald Carlin Professor of Thoracic Surgical Oncology, Miller School of Medicine, University of Miami
Richard Thurer, MD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Chest Physicians, American College of Surgeons, American Medical Association, American Thoracic Society, Florida Medical Association, Society of Surgical Oncology, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Daniel S Schwartz, MD, FACS, Clinical Assistant Professor of Cardiothoracic Surgery, New York University School of Medicine; Consulting Staff, Department of Surgery, Division of Thoracic Surgery, North Shore University Hospital/Long Island Jewish Medical Center
Daniel S Schwartz, MD, FACS is a member of the following medical societies: American Association for the Advancement of Science, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Diabetes Association, American Heart Association, American Medical Association, Association for Academic Surgery, and Society of Thoracic Surgeons
Disclosure: Nothing to disclose.

CME Editor

Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems
Rajalaxmi McKenna, MD, FACP is a member of the following medical societies: American Society of Clinical Oncology, American Society of Hematology, and International Society on Thrombosis and Haemostasis
Disclosure: Nothing to disclose.

Chief Editor

Mary C Mancini, MD, PhD, Professor, Department of Surgery, Louisiana State University Health Sciences Center
Mary C Mancini, MD, PhD is a member of the following medical societies: American Heart Association, American Medical Association, American Thoracic Society, Association for Academic Surgery, Association for Surgical Education, International College of Surgeons, International Society for Heart and Lung Transplantation, New York Academy of Sciences, Phi Beta Kappa, and Southern Thoracic Surgical Association
Disclosure: Nothing to disclose.

RELATED MEDSCAPE ARTICLES
Articles
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.